NeuroscienceFrontiers in Aging NeurosciencePeer-reviewed
Chronic PPARγ Stimulation Shifts Amyloidosis to Higher Fibrillarity but Improves Cognition
Tanja Blume, Maximilian Deußing, Gloria Biechele…·Matthias Brendel
This study shows that chronic PPARγ agonist treatment increases amyloid-beta fibrillarity but improves cognition and synaptic density in mouse models.